GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acurx Pharmaceuticals Inc (NAS:ACXP) » Definitions » Price-to-Tangible-Book

ACXP (Acurx Pharmaceuticals) Price-to-Tangible-Book : 5.58 (As of Dec. 13, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acurx Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-12-13), Acurx Pharmaceuticals's share price is $0.887. Acurx Pharmaceuticals's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was $0.16. Hence, Acurx Pharmaceuticals's Price to Tangible Book Ratio of today is 5.58.

The historical rank and industry rank for Acurx Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

ACXP' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.15   Med: 5.25   Max: 11.95
Current: 5.54

During the past 5 years, Acurx Pharmaceuticals's highest Price to Tangible Book Ratio was 11.95. The lowest was 3.15. And the median was 5.25.

ACXP's Price-to-Tangible-Book is ranked worse than
73.15% of 1203 companies
in the Biotechnology industry
Industry Median: 2.82 vs ACXP: 5.54

A closely related ratio is called PB Ratio. As of today, Acurx Pharmaceuticals's share price is $0.887. Acurx Pharmaceuticals's Book Value per Sharefor the quarter that ended in Sep. 2024 was $0.16. Hence, Acurx Pharmaceuticals's P/B Ratio of today is 5.58.


Acurx Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Acurx Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acurx Pharmaceuticals Price-to-Tangible-Book Chart

Acurx Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - 3.56 6.33 11.86

Acurx Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.95 11.86 6.43 10.51 11.95

Competitive Comparison of Acurx Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Acurx Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acurx Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acurx Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Acurx Pharmaceuticals's Price-to-Tangible-Book falls into.



Acurx Pharmaceuticals Price-to-Tangible-Book Calculation

Acurx Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2024 )
=0.887/0.159
=5.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Acurx Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Acurx Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Acurx Pharmaceuticals Business Description

Traded in Other Exchanges
Address
259 Liberty Avenue, Staten Island, NY, USA, 10305
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.
Executives
David P Luci director, 10 percent owner, officer: President and CEO
Robert J Deluccia director, 10 percent owner 40 WASHINGTON STREET, SUITE 220, WELLESLEY HILLS MA 02481
Carl Sailer director 4 GREENBRIAR LANE, MONTVALE NJ 07645
Thomas L Harrison director
Joseph C Scodari director JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Jack H Dean director C/O RESEARCH PHARMACEUTICAL SERVICES,INC, 520 VIRGINIA DRIVE, FORT WASHINGTON PA 19034
Robert G. Shawah officer: Chief Financial Officer C/O DIPEXIUM PHARMACEUTICALS, LLC, 74 BROAD STREET, NEW YORK NY 10004
James J. Donohue director C/O ACURX PHARMACEUTICALS, INC., 259 LIBERTY AVENUE, STATEN ISLAND NY 10305

Acurx Pharmaceuticals Headlines

From GuruFocus